Advertisement

Pfizer Company Profile

09:44 EDT 25th May 2013 | BioPortfolio

Pfizer Inc, founded in 1849, is dedicated to better health and greater access to healthcare for people and their valued animals. Our purpose is helping people live longer, healthier, happier lives. Our route to that purpose is through discovering and developing breakthrough medicines; providing information on prevention, wellness, and treatment; consistent high-quality manufacturing of medicines, consumer products; and global leadership in corporate responsibility. Every day we help 38 million patients, employ more than 100,000 colleagues, utilize the skills of more than 12,000 medical researchers, and work in partnership with governments, individuals, and other payers for healthcare to treat and prevent illnesses—adding both years to life, and life to years.

Location

235 East 42nd Street
New York
New York
10017
United States of America

Contact

Phone: 1-212-733-2323


News Articles [ 1411 Associated News Articles listed on BioPortfolio]

Pfizer: Company profile

  Return to top 50 pharma list Summary Website: Pfizer Headquarters: New York, USA Ticker: PFE (NYSE) SEC: Pfizer Recent deal news: Pfizer deal news at Current Partnering Must read report: Partne...

Pfizer

Pfizer is a top pharmaceutical company based in New York, USA. The company was founded in 1849. Pfizer are committed to applying science and its global resources to improve health and well-being at ev...

Ex-Pfizer researchers bag $27m for ‘not-a-Pfizer-spin-out’

"This is not a Pfizer spin out," insists Dr Mike Yeadon CEO of new biotech company Ziarco, which has licensed inflammatory and allergic therapeutic candidates from Pfizer and secured a $27 million ser...

Pfizer: M&A activity 2005-2013

Pfizer has also announced 27 M&A deals since 2005, with the lead deals being the acquisition of Wyeth, King and Vicuron. Abstracted from: Partnering Deals and Alliances with Pfizer Pfizer is invol...

Takeda's exclusive distribution of Pfizer products in Japan

Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Japan Inc. ("Pfizer") announced that they have concluded an agreement that, as of December 31, 2012, Takeda will cease distribution of 13 ou...

News Summary: Pfizer buys rights to OTC Nexium

HEARTBURN HEALER: AstraZeneca has sold fellow drugmaker Pfizer the global rights to market a nonprescription version of heartburn drug Nexium, which has annual sales of nearly $8 billlion, starting in...

Pfizer And Hisun announce launch Of Hisun-Pfizer Pharmaceuticals

Pfizer and Zhejiang Hisun Pharmaceuticals announced the launch of Hisun-Pfizer Pharmaceuticals, a joint venture formed between the two companies to develop, manufacture and commercialize off-patent ph...

Pfizer plans split from Zoetis

Pfizer announced its intention to split off its remaining interest in Zoetis, through an exchange offer. Zoetis, formerly Pfizer’s animal health business, completed its initial public offering (...

Drugs and Medications [ 97 Associated Drugs and Medications listed on BioPortfolio]

Preparation h [Pfizer Consumer Healthcare]

Preparation H Suppositories(cocoa butter and phenylephrine HCl)

Chapstick overnight [Pfizer Consumer Healthcare]

ChapStick Overnight Lip Treatment (dimethicone)

Preparation h [Pfizer Consumer Healthcare]

Preparation H Hemorrhoidal Ointment (mineral oil, petrolatum and phenylephrine HCl)

Anbesol cold sore therapy [Pfizer Consumer Healthcare]

Anbesol Cold Sore Therapy(allantoin, benzocaine, camphor, and white petrolatum)

Chapstick lipshield 365 [Pfizer Consumer Healthcare]

Chapstick LipShield 365(avobenzone, dimethicone, homosalate, octinoxate, octisalate, and oxybenzone)

Clinical Trials [ 57 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Blood Levels After Single-Dose Administration Of Artesunate Sachets (Pfizer) Versus Single-Dose Administration Of Arsuamoon® Tablets (Guilin-China) In Healthy Subjects

The primary objective of the study is to determine bioequivalence of 50 mg (2x25 mg) Artesunate Sachet (Pfizer) versus 50 mg (1x50 mg) tablet, Arsuamoon® (Guilin China) which is the World...

A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects

The study will determine if amodiaquine tablet (Pfizer), an antimalaria agent, is pharmaceutically equivalent to a comparator product (Arsuamoon-Guilin China).

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions

An open label, randomized, single-center, single-dose, two-treatment, two-period, crossover bioavailability study comparing Cetirizine Hydrochloride 10 mg tablet of Ohm Laboratories Inc....

Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions

An open label, randomized, single-center, single-dose, two-treatment, two-period, crossover bioavailability study comparing Cetirizine Hydrochloride 10 mg tablet of Ohm Laboratories Inc....

A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

The purpose of this study is to determine bioequivalence of amodiaquine suspension ( Pfizer) and the WHO approved reference product Flavoquine® tablet ( Sanofi Aventis).

Companies [ 84 Associated Companies listed on BioPortfolio]

Renata Limited

Historical High-Lights: Founded in 1972 as a subsidiary of Pfizer Inc. Ownership transferred from Pfizer Inc. to local institutions and the general public in 1993. Company name subsequently changed fr...

Pfizer Ophthalmics

Pfizer Ophthalmics, a division of Pfizer Inc, is committed to preserving sight and eliminating preventable blindness. Pfizer Ophthalmics discovers, develops and provides leading treatments in ophthalm...

Pfizer Consumer Healthcare

Centrum Silver

Pfizer Oncology

Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline, one of the most...

Bristol-Myers Squibb Company & Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-M...

More Information about "Pfizer" on BioPortfolio

We have published hundreds of Pfizer news stories on BioPortfolio along with dozens of Pfizer Clinical Trials and PubMed Articles about Pfizer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pfizer Companies in our database. You can also find out about relevant Pfizer Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement